What is Cabozantinib?

Category: Prescription Drugs

Most popular types: Cometriq


Cabozantinib is a targeted chemotherapy drug used for treatment of metastatic medullary thyroid carcinoma.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 1
Mild 0
None 3

Commonly reported side effects and conditions associated with Cabozantinib

Side effect Patients
Change in hair color 1
Diarrhea 1
Fatigue 1
Hair loss 1
Muscle weakness 1
Shakiness 1


Based on patients currently taking Cabozantinib

Dosage Patients
60 mg daily 1


Currently taking Cabozantinib

Duration Patients
1 - 2 years 1
Adherence Evaluations
Always 3
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 0
Not at all hard to take 3

What people switch to and from

Patients started taking Cabozantinib after stopping:

Treatment Patients
Axitinib (Inlyta) 1
Last updated:
There are no evaluations for Cabozantinib.